28
Participants
Start Date
November 21, 2022
Primary Completion Date
January 9, 2024
Study Completion Date
January 9, 2024
National Human Genome Research Institute (NHGRI), Bethesda
National Institutes of Health Clinical Center, Bethesda
National Human Genome Research Institute (NHGRI)
NIH